| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033259402 |
| P356 | DOI | 10.1038/SJ.ONC.1204393 |
| P698 | PubMed publication ID | 11420694 |
| P5875 | ResearchGate publication ID | 11919133 |
| P2093 | author name string | McCormick F | |
| Ries S | |||
| Haas-Kogan DA | |||
| Yount GL | |||
| Korn M | |||
| Afshar G | |||
| Basila D | |||
| Shalev N | |||
| P2860 | cites work | The receptor for the cytotoxic ligand TRAIL | Q24310481 |
| TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways | Q24317441 | ||
| Identification and characterization of a new member of the TNF family that induces apoptosis | Q24318423 | ||
| Genomic organization, 5' flanking enhancer region, and chromosomal assignment of the cell cycle gene, p55Cdc | Q24318450 | ||
| The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation | Q24318742 | ||
| Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family | Q24320301 | ||
| An antagonist decoy receptor and a death domain-containing receptor for TRAIL | Q28245153 | ||
| Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors | Q28245164 | ||
| KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene | Q28250929 | ||
| Modulation of life and death by the TNF receptor superfamily | Q28295043 | ||
| The TRAIL to selective tumor death | Q28504568 | ||
| Activation of protein kinase C delta by the c-Abl tyrosine kinase in response to ionizing radiation | Q30176208 | ||
| p53-oriented cancer therapies: current progress | Q33545318 | ||
| Regulation of p53 downstream genes. | Q33547816 | ||
| Suppression of Ras-induced apoptosis by the Rac GTPase | Q33959056 | ||
| Induction of apoptosis by the mouse Nedd2 gene, which encodes a protein similar to the product of the Caenorhabditis elegans cell death gene ced-3 and the mammalian IL-1 beta-converting enzyme | Q34325458 | ||
| Cell cycle-regulated expression, phosphorylation, and degradation of p55Cdc. A mammalian homolog of CDC20/Fizzy/slp1. | Q34444604 | ||
| C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent | Q36380929 | ||
| Computer programs for the analysis of cellular survival data. | Q36473991 | ||
| Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression | Q36551292 | ||
| c-Jun-dependent CD95-L expression is a rate-limiting step in the induction of apoptosis by alkylating agents | Q39450413 | ||
| Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. | Q39777499 | ||
| The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation | Q40018513 | ||
| Apoptosis and its role in human disease | Q40534415 | ||
| Radiation therapy of brain tumors | Q40847025 | ||
| Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest | Q40928826 | ||
| Induction of NF-kappaB by the Akt/PKB kinase | Q40950127 | ||
| Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. | Q40975748 | ||
| Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis | Q41007018 | ||
| Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation | Q41064439 | ||
| Effect of ionizing radiation on cell-cycle progression and cyclin B1 expression in human melanoma cells | Q41213544 | ||
| FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis | Q41224805 | ||
| Irradiation Induces WAF1 Expression through a p53-independent Pathway in KG-1 Cells | Q41312629 | ||
| A novel domain within the 55 kd TNF receptor signals cell death | Q41528172 | ||
| A novel DNA damage checkpoint involving post-transcriptional regulation of cyclin A expression | Q42806566 | ||
| The effect of cycloheximide on natural and X-ray-induced cell death in the developing cerebral cortex | Q44556726 | ||
| Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors | Q46041152 | ||
| The effects of O6-benzylguanine and hypoxia on the cytotoxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea in nitrosourea-resistant SF-763 cells | Q46280203 | ||
| Constitutional p53 mutations associated with brain tumors in young adults | Q46575531 | ||
| p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma | Q46680647 | ||
| Accentuated apoptosis in normally developing p53 knockout mouse embryos following genotoxic stress | Q48191611 | ||
| Involvement of the CD95 (APO–1/Fas) receptor/ligand system in drug–induced apoptosis in leukemia cells | Q57384660 | ||
| Epithelial Cells of Different Organs Exhibit Distinct Patterns of p53-Dependent and p53-Independent Apoptosis Following DNA Insult | Q62473027 | ||
| Evidence of internucleosomal DNA fragmentation and identification of dying cells in X-ray-induced cell death in the developing brain | Q62672297 | ||
| Superfractionated radiotherapy in grade III, IV intracranial gliomas | Q69841015 | ||
| Apoptosis in small intestinal epithelial from p53-null mice: evidence for a delayed, p53-independent G2/M-associated cell death after gamma-irradiation | Q73433151 | ||
| How TRAIL kills cancer cells, but not normal cells | Q73632146 | ||
| Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis | Q78093576 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2826-2835 | |
| P577 | publication date | 2001-05-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Transcriptional activation of TRADD mediates p53-independent radiation-induced apoptosis of glioma cells | |
| P478 | volume | 20 |
| Q35847202 | Advances in revealing the molecular targets downstream of oxidative stress-induced proapoptotic kinase signaling in diabetic embryopathy |
| Q39195907 | Androgens regulate TRAIL-induced cell death in prostate cancer cells via multiple mechanisms |
| Q36021584 | Apoptosis in gliomas: molecular mechanisms and therapeutic implications |
| Q39977339 | Chk1 suppresses a caspase-2 apoptotic response to DNA damage that bypasses p53, Bcl-2, and caspase-3. |
| Q48197073 | Combination treatment of TRAIL, DFMO and radiation for malignant glioma cells |
| Q36662230 | ERK mediated upregulation of death receptor 5 overcomes the lack of p53 functionality in the diaminothiazole DAT1 induced apoptosis in colon cancer models: efficiency of DAT1 in Ras-Raf mutated cells |
| Q77628113 | Genomic plasticity in cell death susceptibility |
| Q24672792 | Inositol hexakisphosphate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics |
| Q38360588 | Involvement of FKHR-dependent TRADD expression in chemotherapeutic drug-induced apoptosis |
| Q34590759 | Mechanisms of apoptosis in central nervous system tumors: application to theory |
| Q37328291 | Modulation of Radiation-Induced Genetic Damage by HCMV in Peripheral Blood Lymphocytes from a Brain Tumor Case-Control Study |
| Q35011239 | Molecular mechanisms of irradiation-induced apoptosis |
| Q40639880 | Perillyl alcohol as a radio-/chemosensitizer in malignant glioma |
| Q39352683 | Radioresistance of human glioma spheroids and expression of HSP70, p53 and EGFr |
| Q51225202 | Sublytic C5b-9 Induces Glomerular Mesangial Cell Apoptosis through the Cascade Pathway of MEKK2-p38 MAPK-IRF-1-TRADD-Caspase 8 in Rat Thy-1 Nephritis. |
Search more.